BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Marvin 2D Structure

The following exact ligands are found in BindingDB

Wt: 474.5
BDBM199356

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)

Found 7 hits in this display   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Kappa-type opioid receptor


(Homo sapiens (Human))
BDBM199356
PNG
(US9221831, 21)
Show SMILES CO[C@]12CC[C@@]3(C[C@@H]1COCc1ccccc1)[C@H]1Cc4ccc(C(N)=O)c5O[C@@H]2[C@]3(CCN1C)c45 |r,TLB:8:7:29.28:4.3|
Show InChI InChI=1S/C29H34N2O4/c1-31-13-12-28-23-19-8-9-21(25(30)32)24(23)35-26(28)29(33-2)11-10-27(28,22(31)14-19)15-20(29)17-34-16-18-6-4-3-5-7-18/h3-9,20,22,26H,10-17H2,1-2H3,(H2,30,32)/t20-,22-,26-,27-,28+,29-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.150n/an/an/an/an/an/a7.4n/a



Purdue Pharma, L.P.

US Patent


Assay Description
Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...


US Patent US9221831 (2015)


BindingDB Entry DOI: 10.7270/Q2T72G8M
More data for this
Ligand-Target Pair
Mu-type opioid receptor


(Homo sapiens (Human))
BDBM199356
PNG
(US9221831, 21)
Show SMILES CO[C@]12CC[C@@]3(C[C@@H]1COCc1ccccc1)[C@H]1Cc4ccc(C(N)=O)c5O[C@@H]2[C@]3(CCN1C)c45 |r,TLB:8:7:29.28:4.3|
Show InChI InChI=1S/C29H34N2O4/c1-31-13-12-28-23-19-8-9-21(25(30)32)24(23)35-26(28)29(33-2)11-10-27(28,22(31)14-19)15-20(29)17-34-16-18-6-4-3-5-7-18/h3-9,20,22,26H,10-17H2,1-2H3,(H2,30,32)/t20-,22-,26-,27-,28+,29-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
17.3 -48.0n/an/an/an/an/a7.450



Purdue Pharma, L.P.

US Patent


Assay Description
Radioligand dose-displacement binding assays for t-opioid receptors used 0.3 nM [3H]-diprenorphine (Perkin Elmer, Shelton, Conn.), with 5 mg membrane...


US Patent US9221831 (2015)


BindingDB Entry DOI: 10.7270/Q2T72G8M
More data for this
Ligand-Target Pair
Delta-type opioid receptor


(Homo sapiens (Human))
BDBM199356
PNG
(US9221831, 21)
Show SMILES CO[C@]12CC[C@@]3(C[C@@H]1COCc1ccccc1)[C@H]1Cc4ccc(C(N)=O)c5O[C@@H]2[C@]3(CCN1C)c45 |r,TLB:8:7:29.28:4.3|
Show InChI InChI=1S/C29H34N2O4/c1-31-13-12-28-23-19-8-9-21(25(30)32)24(23)35-26(28)29(33-2)11-10-27(28,22(31)14-19)15-20(29)17-34-16-18-6-4-3-5-7-18/h3-9,20,22,26H,10-17H2,1-2H3,(H2,30,32)/t20-,22-,26-,27-,28+,29-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
185 -38.4n/an/an/an/an/a7.425



Purdue Pharma, L.P.

US Patent


Assay Description
Delta-opioid Receptor Binding Assay Procedures were conducted as follows. Radioligand dose-displacement assays used 0.3 nM [3H]-Naltrindole (Perkin...


US Patent US9221831 (2015)


BindingDB Entry DOI: 10.7270/Q2T72G8M
More data for this
Ligand-Target Pair
Opioid growth factor receptor-like protein 1


(Homo sapiens (Human))
BDBM199356
PNG
(US9221831, 21)
Show SMILES CO[C@]12CC[C@@]3(C[C@@H]1COCc1ccccc1)[C@H]1Cc4ccc(C(N)=O)c5O[C@@H]2[C@]3(CCN1C)c45 |r,TLB:8:7:29.28:4.3|
Show InChI InChI=1S/C29H34N2O4/c1-31-13-12-28-23-19-8-9-21(25(30)32)24(23)35-26(28)29(33-2)11-10-27(28,22(31)14-19)15-20(29)17-34-16-18-6-4-3-5-7-18/h3-9,20,22,26H,10-17H2,1-2H3,(H2,30,32)/t20-,22-,26-,27-,28+,29-/m1/s1
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
8.62E+3 -31.3n/an/an/an/an/a7.450



Purdue Pharma, L.P.

US Patent


Assay Description
Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (Perkin Elmer, Shelton, Conn.; 87.7 Ci/mmole) with 12 ug mem...


US Patent US9221831 (2015)


BindingDB Entry DOI: 10.7270/Q2T72G8M
More data for this
Ligand-Target Pair
Delta-type opioid receptor


(Homo sapiens (Human))
BDBM199356
PNG
(US9221831, 21)
Show SMILES CO[C@]12CC[C@@]3(C[C@@H]1COCc1ccccc1)[C@H]1Cc4ccc(C(N)=O)c5O[C@@H]2[C@]3(CCN1C)c45 |r,TLB:8:7:29.28:4.3|
Show InChI InChI=1S/C29H34N2O4/c1-31-13-12-28-23-19-8-9-21(25(30)32)24(23)35-26(28)29(33-2)11-10-27(28,22(31)14-19)15-20(29)17-34-16-18-6-4-3-5-7-18/h3-9,20,22,26H,10-17H2,1-2H3,(H2,30,32)/t20-,22-,26-,27-,28+,29-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 86n/an/a7.425



Purdue Pharma, L.P.

US Patent


Assay Description
Functional [35S]GTPgammaS binding assays were conducted as follows. Delta opioid receptor membrane solution was prepared by sequentially adding fin...


US Patent US9221831 (2015)


BindingDB Entry DOI: 10.7270/Q2T72G8M
More data for this
Ligand-Target Pair
Mu-type opioid receptor


(Homo sapiens (Human))
BDBM199356
PNG
(US9221831, 21)
Show SMILES CO[C@]12CC[C@@]3(C[C@@H]1COCc1ccccc1)[C@H]1Cc4ccc(C(N)=O)c5O[C@@H]2[C@]3(CCN1C)c45 |r,TLB:8:7:29.28:4.3|
Show InChI InChI=1S/C29H34N2O4/c1-31-13-12-28-23-19-8-9-21(25(30)32)24(23)35-26(28)29(33-2)11-10-27(28,22(31)14-19)15-20(29)17-34-16-18-6-4-3-5-7-18/h3-9,20,22,26H,10-17H2,1-2H3,(H2,30,32)/t20-,22-,26-,27-,28+,29-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 102n/an/a7.425



Purdue Pharma, L.P.

US Patent


Assay Description
[35S]GTPgammaS functional assays were conducted using freshly thawed u-receptor membranes (Perkin Elmer, Shelton, Conn.). Assay reactions were prepa...


US Patent US9221831 (2015)


BindingDB Entry DOI: 10.7270/Q2T72G8M
More data for this
Ligand-Target Pair
Kappa-type opioid receptor


(Homo sapiens (Human))
BDBM199356
PNG
(US9221831, 21)
Show SMILES CO[C@]12CC[C@@]3(C[C@@H]1COCc1ccccc1)[C@H]1Cc4ccc(C(N)=O)c5O[C@@H]2[C@]3(CCN1C)c45 |r,TLB:8:7:29.28:4.3|
Show InChI InChI=1S/C29H34N2O4/c1-31-13-12-28-23-19-8-9-21(25(30)32)24(23)35-26(28)29(33-2)11-10-27(28,22(31)14-19)15-20(29)17-34-16-18-6-4-3-5-7-18/h3-9,20,22,26H,10-17H2,1-2H3,(H2,30,32)/t20-,22-,26-,27-,28+,29-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 13.3n/an/a7.425



Purdue Pharma, L.P.

US Patent


Assay Description
Functional [35S]GTPgammaS binding assays were conducted as follows. κ opioid receptor membrane solution was prepared by sequentially adding final ...


US Patent US9221831 (2015)


BindingDB Entry DOI: 10.7270/Q2T72G8M
More data for this
Ligand-Target Pair